Vaniprevir

Vaniprevir
Identifiers
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL599872;
ECHA InfoCard	100.207.830
	SMILES CC(C)(C)[C@H]1NC(=O)OCC(C)(C)CCCCc2cccc3CN(Cc23)C(=O)O[C@H]4C[C@@H](N(C4)C1=O)C(=O)N[C@@]5(C[C@H]5C=C)C(=O)NS(=O)(=O)C6CC6;
Properties
Chemical formula	C38H53N5O9S
Molar mass	755.9 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Vaniprevir (MK-7009) is a macrocyclic Hepatitis C virus (HCV) NS3/4a protease inhibitor, developed by Merck, which is currently in clinical testing. ^[1]

References

^ McCauley, John A. (2010). "Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor". Journal of Medicinal Chemistry: JMedChem. 53 (6): 2443–2463. doi:10.1021/jm9015526. {{cite journal}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)